This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.
Leela Barham and Tim Wilsdon discuss the potential impact that value-based pricing (VBP) may have in the UK and the broader implications for developing international models of Health Technology Assessment (HTA). The article can be found here:
As the COVID-19 pandemic continues around the world, global efforts among industry stakeholders to develop, manufacture and secure the supply of proven...
Growing evidence indicates that imbalances in bacteria living in the human microbiome can lead to a range of diseases that can potentially be treated by...
CRA is proud to support the New England region of the LLS Man & Woman of the year campaign, a philanthropic competition to support blood cancer research. Ned...
Anthony Barron is moderating an “Issue Panel” on Comprehensive Genomic Profiling (CGP). For more information on this event, click here.
